Presynaptic calcium-dependent acetylcholine release machinery (NMJ-AR machinery)

The presynaptic calcium-dependent acetylcholine release machinery at the neuromuscular junction (NMJ) is a complex multi-protein system essential for motor control (StatPearls, 2023). It functions by transducing electrical impulses from motor neurons into the chemical release of acetylcholine (ACh) into the synaptic cleft. Key components include P/Q-type voltage-gated calcium channels (VGCCs), the SNARE complex (comprising syntaxin-1, SNAP-25, and synaptobrevin/VAMP), and the calcium sensor synaptotagmin (Tarr et al., 2015). When an action potential reaches the nerve terminal, VGCCs open, and the resulting calcium influx triggers synaptotagmin to facilitate the rapid fusion of ACh-filled vesicles with the plasma membrane. This machinery is the primary target of botulinum neurotoxins, which proteolytically cleave SNARE proteins to prevent vesicle fusion, causing flaccid muscle paralysis (Rossetto et al., 2014). It is also the site of pathology in Lambert-Eaton Myasthenic Syndrome (LEMS), where autoantibodies target the P/Q-type calcium channels, leading to reduced ACh release (Titulaer et al., 2011). Pharmacological agents like amifampridine target this system by blocking potassium channels, thereby prolonging the presynaptic action potential and increasing calcium-mediated ACh release to treat neuromuscular weakness.

Other names

SNARE complexPresynaptic active zoneAcetylcholine release apparatusPresynaptic exocytotic machineryNMJ neurotransmitter release complex

Inhibition of neurotransmitter release via proteolytic cleavage of SNARE proteins (e.g., SNAP-25, Syntaxin, or VAMP) or enhancement of release by blocking presynaptic potassium channels to prolong calcium influx.